Retatrutide
Effects of retatrutide on body composition in people with type 2 diabetes: a phase 2 trial substudy
Journal: The Lancet Diabetes and Endocrinology. Publication date: August 2025. PMID: 40609566. DOI: 10.1016/S2213-8587(25)00092-0. This substudy examined body-composition outcomes in a phase 2 retatrutide trial.
Limitations and interpretation
A substudy is not equivalent to a standalone trial designed to establish every possible clinical outcome.
Open original source / literature record ↗